| Code | 75535 | ||||||||||
| MA number | 44/0264/09-S | ||||||||||
| Product Form: | tbl flm 30x2,5 mg (blis. PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 05.05.2009 |
| PIL: |
PIL_LetrozolePharmacenter 2,5 mg_06/2020.doc.doc
|
| SPC: |
SPC_LetrozolePharmacenter 2,5 mg_06/2020.doc.doc
|
| Safety feature | Yes |
| Data update: | 17.10.2018 |
